Blackstone Providing $750 M To Fund Moderna’s Influenza Program
By
Moderna, a Cambridge, Massachusetts-based bio/pharmaceutical company, and Blackstone, an investment-management firm, have announced a new collaboration under which Blackstone will provide up to $750 million to fund Moderna’s influenza program. …